N4 Pharma Plc (N4P.L)
N4P.L Stock Price Chart
Explore N4 Pharma Plc interactive price chart. Choose custom timeframes to analyze N4P.L price movements and trends.
N4P.L Company Profile
Discover essential business fundamentals and corporate details for N4 Pharma Plc (N4P.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1 Jul 1988
Employees
5.00
Website
https://www.n4pharma.comCEO
Nigel James Theobald
Description
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
N4P.L Financial Timeline
Browse a chronological timeline of N4 Pharma Plc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 22 Sept 2025
Earnings released on 11 Jun 2025
Revenue for the quarter reached £3.38K.
Earnings released on 24 Sept 2024
EPS came in at -£0.00, while revenue for the quarter reached £3.91K.
Earnings released on 23 Apr 2024
EPS came in at -£0.00, while revenue for the quarter reached £1.95K.
Earnings released on 12 Sept 2023
EPS came in at -£0.00.
Earnings released on 9 Mar 2023
EPS came in at -£0.00.
Earnings released on 30 Jun 2022
EPS came in at -£0.00.
Earnings released on 31 Dec 2021
EPS came in at -£0.00.
Earnings released on 30 Jun 2021
EPS came in at -£0.01.
Earnings released on 31 Dec 2020
EPS came in at -£0.00.
N4P.L Stock Performance
Access detailed N4P.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.